635 A randomised, placebo-controlled, phase I/IIa study evaluating the safety and clinical activity of a novel cancer vaccine (ITOP1) in patients with resectable oesophageal adenocarcinoma (VISTA study)
Grant M., Kwok J., Smith P., Lee LN., Chinnakannan S., Tong O., Thompson D., Klenerman P., Ternette N., Middleton M.